GBA Gene Mutation

8 registered clinical trials studyying GBA Gene Mutation — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	High-Dose Ambroxol in GBA1-Related Parkinson NCT06193421	Agyany Pharma LTD	Phase 1 / Phase 2
Recruiting	Drug Discovery for Parkinson's With Mutations in the GBA Gene NCT05536388	New York Stem Cell Foundation Research Institute	—
Completed	Ambroxol as a Disease-modifying Treatment in GBA-PD NCT05287503	Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta	Phase 2
Unknown	Evaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's Disease NCT04387812	Tel-Aviv Sourasky Medical Center	N/A
Unknown	World Data on Ambroxol for Patients With GD and GBA Related PD NCT04388969	Shaare Zedek Medical Center	—
Recruiting	The GBA Multimodal Study in Parkinson's Disease NCT04101968	Pacific Parkinson's Research Centre	—
Completed	LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Dise NCT04668898	Icahn School of Medicine at Mount Sinai	—
Completed	Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers NCT03234478	Rutgers, The State University of New Jersey	—